Climb Bio, Inc. - Common Stock (NQ:CLYM)
2.080
-0.020
(-0.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 28, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 493,403 |
| Open | 2.120 |
| Bid (Size) | 1.970 (30) |
| Ask (Size) | 2.200 (279) |
| Prev. Close | 2.100 |
| Today's Range | 1.950 - 2.120 |
| 52wk Range | 1.050 - 4.450 |
| Shares Outstanding | 26,993,401 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 04, 2025
Top movers in Thursday's after hours session
July 03, 2025
Friday's after hours session: top gainers and losers
April 11, 2025
Climb Bio to Present at Upcoming Investor Conferences
February 25, 2025
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
February 24, 2025
Frequently Asked Questions
Is Climb Bio, Inc. - Common Stock publicly traded?
Yes, Climb Bio, Inc. - Common Stock is publicly traded.
What exchange does Climb Bio, Inc. - Common Stock trade on?
Climb Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Climb Bio, Inc. - Common Stock?
The ticker symbol for Climb Bio, Inc. - Common Stock is CLYM on the Nasdaq Stock Market
What is the current price of Climb Bio, Inc. - Common Stock?
The current price of Climb Bio, Inc. - Common Stock is 2.080
When was Climb Bio, Inc. - Common Stock last traded?
The last trade of Climb Bio, Inc. - Common Stock was at 10/28/25 04:00 PM ET
What is the market capitalization of Climb Bio, Inc. - Common Stock?
The market capitalization of Climb Bio, Inc. - Common Stock is 56.15M
How many shares of Climb Bio, Inc. - Common Stock are outstanding?
Climb Bio, Inc. - Common Stock has 56M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.